Fanconi anaemia

Journal of Medical Genetics

Volumn 40, Issue 1, 2003, Pages 1-10

  Tischkowitz, M D ^a   Hodgson, S V ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; OXYMETHOLONE; PROTEIN; PROTEIN FANCB; UNCLASSIFIED DRUG;

ACNE; ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; AUTOSOMAL RECESSIVE DISORDER; CELL CYCLE; CHROMOSOME BREAKAGE; CLINICAL FEATURE; CONGENITAL DISORDER; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; FANCONI ANEMIA; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENE THERAPY; GENE TRANSFER; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK POPULATION; HUMAN; HYPERACTIVITY; INCIDENCE; LIVER ADENOMA; LIVER CARCINOMA; MOLECULAR CLONING; MOSAICISM; NIJMEGEN BREAKAGE SYNDROME; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; SHORT STATURE; SOLID TUMOR; TELOMERE; VIRILIZATION;

EID: 0037238768     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.40.1.1     Document Type: Review

References (143)

1. Fanconi G. Familiaere infantile perniziosaartige Anaemie (pernizioeses Blutbild und Konstitution). Jahrbuch Kinderheild 1927;117:257-80.
2. Alter BP. Fanconi's anemia and malignancies. Am J Hematol 1996;53:99-110.
3. Auerbach AD, Wolman SR. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinagens. Nature 1976;261:494-6.
4. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 1993;21:731-3.
5. Joenje H, Oostra AB, Wijker M, Di SFM, Van BCG, Rooimans MA, Ebell W, Van WM, Pronk JC, Buchwald M, Arwert F. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet 1997;61:940-4.
6. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, Alan N, Wijker M, Parker L, Lightfoot J, Carreau M, Callen DF, Savoia A, Cheng NC, van Berkel CG, Strunk MH, Gille JJ, Pals G, Kruyt FA, Pronk JC, Arwert F, Buchwald M, Joenje H. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet 1996;14:320-3.
7. The Fanconi Anaemia/Breast Cancer Consortium, Positional cloning of the Fanconi anaemia group A gene. Nat Genet 1996;14:324-8.
8. Strathdee CA, Duncan AM, Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1992;1:196-8.
9. Timmers C, Taniguchi T, Hejna J, Reifsteck C, Lucas L, Bruun D, Thayer M, Cox B, Olson S, D'Andrea AD, Moses R, Grompe M. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell 2001;7:241-8.
10. de Winter JP, Rooimans MA, van Der Weel L, van Berkel CG, Alon N, Bosnoyan-Collins L, de Groot J, Zhi Y, Waisfisz Q, Pronk JC, Arwert F, Mathew CG, Scheper RJ, Hoatlin ME, Buchwald M, Joenje H. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet 2000;24:15-16.
11. de Winter JP, Leveille F, van Berkel CG, Rooimans MA, van der Weel L, Steltenpaal J, Demuth I, Morgan NV, Alon N, Bosnayan-Callins L, Lightfoot J, Leegwater PA, Waisfisz Q, Kamatsu K, Arwert F, Prank JC, Mathew CG, Digweed M, Buchwald M, Joenje H. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet 2000;67:5.
12. de Winter JP, Waisfisz Q, Rooimans MA, Van Berkel CGM, Bosnoyan-Collins L, Alan N, Carreau M, Bender O, Demuth I, Schindler D, Pronk JC, Arwert F, Hoehn H, Digweed M, Buchwald M, Joenje H. The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet 1998;20:281-3.
13. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA, D'Andrea AD. Biallelic inactivation of BRCA2 in fanconi anemia. Science 2002;297:606-9.
14. Joenje H, Arwert F. Connecting Fanconi anemia to BRCA1. Nat Med 2001;7:406-7.
15. Taniguchi T, Garcia-Higuera I, Xu B, Gregory RC, Kim ST, Lane WS, Kastan MB, D'Andrea AD. Convergence of the Fanconi anaemia and ataxia telangiectasia signaling pathways. Cell 2002;109:459-72.
16. Witt E, Ashworth A. D-day for BRCA2. Science 2002;297:534.
17. Schroeder TM, Tilgen D, Kruger J, Vogel F. Formal genetics of Fanconi's anemia. Hum Genet 1976;32:257-88.
18. Swift M. Fanconi's anaemia in the genetics of neoplasia. Nature 1971;230:370-3.
19. Alter BP. Clinical features of Fanconi's anaemia. In: Young NS, Alter BP, eds. Aplastic anemia: acquired and inherited. Philadelphia: Saunders, 1994:275-308.
20. Verlander PC, Kaporis A, Liu Q, Zhang Q, Seligsohn U, Auerbach AD. Carrier frequency of the IVS4 + 4 A→T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood 1995;86:4034-8.
21. Rosendorff J, Bernstein R, Macdougall L, Jenkins T. Fanconi anemia: another disease of unusually high prevalence in the Afrikaans population of South Africa. Am J Med Genet 1987;27:793-7.
22. Auerbach A, Buchwald M, Joenje H. Fanconi anaemia. In: Vogelstein B, Kinzler KW, eds. The genetic basis of human cancer. New York: McGraw Hill, 1999:317-32.
23. De Kerviler E, Guermazi A, Zagdanski AM, Gluckman E, Frija J. The clinical and radiological features of Fanconi's anaemia. Clin Radiol 2000;55:340-5.
24. Wajnrajch MP, Gertner JM, Huma Z, Popovic J, Lin K, Verlander PC, Batish SD, Giampietro PF, Davis JG, New MI, Auerbach AD. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 2001;107:744-54.
25. Liu JM, Auerbach AD, Young NS. Fanconi anemia presenting unexpectedly in an adult kindred with no dysmorphic features. Am J Med 1991;91:555-7.
26. Alter BP, Frissora CL, Halperin DS, Freedman MH, Chitkara U, Alvarez E, Lynch L, Adler-Brecher B, Auerbach AD. Fanconi's anaemia and pregnancy. Br J Haematol 1991;7:410-18.
27. Kaplan MJ, Sabio H, Wanebo HJ, Cantrell RW. Squamous cell carcinoma in the immunosuppressed patient: Fanconi's anemia. Laryngoscope 1985;95:771-5.
28. Koc A, Pronk JC, Alikasifoglu M, Joenje H, Altay C. Variable pathogenicity of exon 43del (FAA) in four Fanconi anaemia patients within a consanguineous family. Br J Haematol 1999;104:127-30.
29. Giampietro PF, Verlander PC, Davis JG, Auerbach AD. Diagnosis of Fanconi anemia in patients without congenital malformations: an International Fanconi Anemia Registry study. Am J Med Genet 1997;68:58-61.
30. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet 1991;51:1-12.
31. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. Hematalogic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood 1994;84:1650-5.
32. Head DR. Revised classification of acute myeloid leukemia. Leukemia 1996;10:1826-31.
33. Swift M, Caldwell RJ, Chase C. Reassessment of cancer predisposition of Fanconi anemia heterazygotes. J Natl Cancer Inst 1980;65:863-7.
34. Potter NU, Sarmousakis C, Li FP. Cancer in relatives of patients with aplastic anemia. Cancer Genet Cytogenet 1983;9:61-5.
35. German J, Schonberg S, Caskie S, Warburton D, Falk C, Ray JH. A test for Fanconi's anemia. Blood 1987;69:1637-41.
36. Auerbach AD. A test for Fanconi's anemia. Blood 1988;72:366-7.
37. Auerbach AD, Sagi M, Adler B. Fanconi anemia: prenatal diagnosis in 30 fetuses at risk. Pediatrics 1985;76:794-800.
38. Dutrillaux B, Aurias A, Dutrillaux AM, Buriot D, Prieur M. The cell cycle of lymphocytes in Fanconi anemia. Hum Genet 1982;62:327-32.
39. Schindler D, Kubbies M, Hoehn H, Schinzel A, Rabinovitch PS. Presymptomatic diagnosis of Fanconi's anaemia. Lancet 1985;i:937.
40. Seyschab H, Friedl R, Sun Y, Schindler D, Hoehn H, Hentze S, Schroeder-Kurth T. Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia. Blood 1995;85:2233-7.
41. Berger R, Le Coniat M, Gendron MC. Fanconi anemia. Chromosome breakage and cell cycle studies. Cancer Genet Cytogenet 1993;69:13-16.
42. Toraldo R, Canino G, Tolone C, D'Avanzo M, Porfirio B, Hoehn H, Schroeder-Kurth T, Pistoia V. Variable response to the diepoxybutane test in two dizygotic twins with Fanconi's anemia and flow cytometry for diagnosis confirmation. Pediatr Hematol Oncol 1998;15:45-54.
43. Hanenberg H, Batish SD, Pollok KE, Vieten L, Verlander PC, Leurs C, Coaper RJ, Gattsche K, Haneline L, Clapp DW, Labitz S, Williams DA, Auerbach AD. Phenatypic carrectian af primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. Exp Hematol 2002;30:410-20.
44. Hall JG. Thrombocytopenia and absent radius (TAR) syndrome. J Med Genet 1987;24:79-83.
45. Hedberg VA, Lipton JM. Thrombocytopenia with absent radii. A review of 100 cases. Am J Pediatr Hematol Oncol 1988;10:51-64.
46. Dianzani I, Garelli; E, Ramenghi U. Diamond-Blackfan anaemia: an overview. Paediatr Drugs 2000;2:345-55.
47. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, Beckmann G, Seemanova E, Cooper PR, Nowak NJ, Stumm M, Weemaes CM, Gatti RA, Wilson RK, Digweed M, Rosenthal A, Sperling K, Concannon P, Reis A. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 1998;93:467-76.
48. Cerosaletti KM, Lange E, Stringham HM, Weemaes CM, Smeets D, Solder B, Belohradsky BH, Taylor AM, Karnes P, Elliott A, Komatsu K, Gatti RA, Boehnke M, Concannon P. Fine localization of the Nijmegen breakage syndrome gene to 8q21: evidence for a common founder haplotype. Am J Hum Genet 1998;63:125-34.
49. Resnick IB, Kondratenko I, Togoev O, Vasserman N, Shagina I, Evgrafov O, Tverskaya S, Cerosaletti KM, Gatti RA, Concannon P. Nijmegen breakage syndrome: clinical characteristics and mutation analysis in eight unrelated Russian families. J Pediatr 2002;140:355-61.
50. Dokal I, Chase A, Morgan NV, Coulthard S, Hall G, Mathew CG, Roberts I. Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anaemia complementation group C mutations. Br J Haematol 1996;93:813-18.
51. Lo Ten Foe JR, Kwee ML, Rooimans MA, Oostra AB, Veerman AJ, van Weel M, Pauli RM, Shahidi NT, Dokal I, Roberts I, Altay C, Gluckman E, Gibson RA, Mathew CG, Arwert F, Joenje H. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet 1997;5:137-48.
52. Gregory JJ Jr, Wagner JE, Verlander PC, Levran O, Batish SD, Eide CR, Steffenhagen A, Hirsch B, Auerbach AD. Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proc Natl Acad Sci USA 2001;98:2532-7.
53. Waisfisz Q, Morgan NV, Savino M, de Winter JP, van Berkel CG, Hoatlin ME, Ianzano L, Gibson RA, Arwert F, Savoia A, Mathew CG, Pronk JC, Joenje H. Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nat Genet 1999;22:379-83.
54. Rackoff WD. Treatment of bone marrow failure. In: Owen J, ed. Fanconi anemia - standards for clinical care. Fanconi Anemia Research Fund Inc, 1902 Jefferson Street, Suite 2, Eugene, Oregon 97405, 1999:9-20.
55. Pavlatos AM, Fultz O, Monberg MJ, Vootkur A, Pharm D. Review of oxymetholone: a 17alpha-alkylated anabolic-androgenic steroid. Clin Ther 2001;23:789-801; discussion 771.
56. Gluckman E. Radiosensitivity in Fanconi anemia: application to the conditioning for bone marrow transplantation. Radiother Oncol 1990;18(suppl 1):88-93.
57. Berger R, Bernheim A, Gluckman E, Gisselbrecht C. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients. Br J Haematol 1980;45:565-8.
58. Guardiola P, Socie G, Pasquini R, Dokal I, Ortega JJ, van Weel-Sipman M, Marsh J, Locatelli F, Souillet G, Cahn JY, Ljungman P, Miniero R, Shaw J, Vermylen C, Archimbaud E, Bekassy AN, Krivan G, Di Bartolomeo P, Bacigalupo AL, Gluckman E. Allogeneic stem cell transplantation for Fanconi anaemia. Severe Aplastic Anaemia Working Party of the EBMT and EUFAR. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998;21 (suppl 2):S24-7.
59. McCloy M, Almeida A, Daly P, Vulliamy T, Roberts IA, Dokal I. Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation. Br J Haematol 2001;112:427-9.
60. MacMillan ML, Auerbach AD, Davies SM, Defor TE, Gillio A, Giller R, Harris R, Cairo M, Dusenbery K, Hirsch B, Ramsay NK, Weisdorf DJ, Wagner JE. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. Br J Haematol 2000;109:121-9.
61. Verlinsky Y, Rechitsky S, Schoolcraft W, Strom C, Kuliev A. Preimplantation diagnosis for Fanconi anemia combined with HLA matching. JAMA 2001;285:3130-3.
62. Damewood MD. Ethical implications of a new application of preimplantation diagnosis. JAMA 2001;285:3143-4.
63. Deeg HJ, Socie G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, Sullivan KM, Gluckman E, Storb R. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996;87:386-92.
64. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983;54:431-40.
65. Marcou Y, D'Andrea A, Jeggo PA, Plowman PN. Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity. Radiother Oncol 2001;60:75-9.
66. Alter BP. Radiosensitivity in Fanconi's anemia patients. Radiother Oncol 2002;62:345-7.
67. Gush KA, Fu KL, Grompe M, Walsh CE. Phenotypic correction of Fanconi anemia group C knockout mice. Blood 2000;95:700-4.
68. Liu JM, Kim S, Read EJ, Futaki M, Dokal I, Carter CS, Leitman SF, Pensiero M, Young NS, Walsh CE. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther 1999;10:2337-46.
69. Galimi F, Noll M, Kanazawa Y, Lax T, Chen C, Grompe M, Verma IM. Gene therapy of Fanconi anaemia by lentivectors. Blood 2002;100:2732-6.
70. Joenje H, Levitus M, Waisfisz Q, D'Andrea A, Garcia-Higuera I, Pearson T, van Berkel CG, Rooimans MA, Morgan N, Mathew CG, Arwert F. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am J Hum Genet 2000;67:759-62.
71. Cheng NC, van De Vrugt HJ, van Der Valk MA, Oostra AB, Krimpenfort P, de Vries Y, Joenje H, Berns A, Arwert F. Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum Mol Genet 2000;9:1805-11.
72. Chen M, Tomkins DJ, Auerbach W, McKerlie C, Youssoufian H, Liu L, Gan O, Carreau M, Auerbach A, Groves T, Guidos CJ, Freedman MH, Cross J, Percy DH, Dick JE, Joyner AL, Buchwald M. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat Genet 1996;12:448-51.
73. Whitney MA, Royle G, Low MJ, Kelly MA, Axthelm MK, Reifsteck C, Olson S, Braun RE, Heinrich MC, Rathbun RK, Bagby GC, Grompe M. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood 1996;88:49-58.
74. Koomen M, Cheng NC, van De Vrugt HJ, Godthelp BC, van Der Valk MA, Oostra AB, Zdzienicka MZ, Joenje H, Arwert F. Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice. Hum Mol Genet 2002;11:273-81.
75. Levran O, Erlich T, Magdalena N, Gregory JJ, Batish SD, Verlander PC, Auerbach AD. Sequence variation in the Fanconi anemia gene FAA. Proc Natl Acad Sci USA 1997;94:13051-6.
76. Wijker M, Morgan NV, Herterich S, van Berkel CG, Tipping AJ, Gross HJ, Gille JJ, Pals G, Savino M, Altay C, Mohan S, Dokal I, Cavenagh J, Marsh J, van Weel M, Ortega JJ, Schuler D, Samochatova E, Karwacki M, Bekassy AN, Abecasis M, Ebell W, Kwee ML, de Ravel T, et al. Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet 1999;7:52-9.
77. Morgan NV, Tipping AJ, Joenje H, Mathew CG. High frequency of large intragenic deletions in the Fanconi anemia group A gene. Am J Hum Genet 1999;65:1330-41.
78. Savino M, Ianzano L, Strippoli P, Ramenghi U, Arslanian A, Bagnara GP, Joenje H, Zelante L, Savoia A. Mutations of the Fanconi anemia group A gene (FAA) in Italian patients. Am J Hum Genet 1997;61:1246-53.
79. Centra M, Memeo E, d'Apolito M, Savino M, Ianzano L, Notarangelo A, Liu J, Doggett NA, Zelante L, Savoia A. Fine exon-intron structure of the Fanconi anemia group A (FAA) gene and characterization of two genomic deletions. Genomics 1998;51:463-7.
80. Levran O, Doggett NA, Auerbach AD. Identification of Alu-mediated deletions in the Fanconi anemia gene FAA. Hum Mutat 1998;12:145-52.
81. Tipping AJ, Pearson T, Morgan NV, Gibson RA, Kuyt LP, Havenga C, Gluckman E, Joenje H, de Ravel T, Jansen S, Mathew CG. Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. Proc Natl Acad Sci USA 2001;98:5734-9.
82. van de Vrugt HJ, Cheng NC, de Vries Y, Rooimans MA, de Groot J, Scheper RJ, Zhi Y, Hoatlin ME, Joenje H, Arwert F. Claning and characterization of murine fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis, and ovary. Mamm Genome 2000;11:326-31.
83. Walsh CE, Yountz MR, Simpson DA. Intracellular localization of the Fanconi anemia complementation group A protein. Biochem Biophys Res Commun 1999;259:594-9.
84. Gillio AP, Verlander PC, Batish SD, Giampietro PF, Auerbach AD. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Blood 1997;90:105-10.
85. Yamashita T, Wu N, Kupfer G, Corless C, Joenje H, Grompe M, D'Andrea AD. Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity. Blood 1996;87:4424-32.
86. Futaki M, Yamashita T, Yagasaki H, Toda T, Yabe M, Kato S, Asano S, Nakahata T. The IVS4 + 4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. Blood 2000;95:1493-8.
87. Kupfer GM, Näf D, Suliman A, Pulsipher M, D'Andrea AD. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nat Genet 1997;17:487-90.
88. Patel KJ, Vu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA, Venkitaraman AR. Involvement of Brca2 in DNA repair. Mol Cell 1998;1:347-57.
89. Tutt A, Gabriel A, Bertwistle D, Connor F, Paterson H, Peacock J, Ross G, Ashworth A. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr Biol 1999;9:1107-10.
90. Garcia-Higuero I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J Grompe M D'Andrea AD. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001;7:249-62.
91. Liu N, Lamerdin JE, Tucker JD, Zhou ZQ, Walter CA, Albala JS, Busch DB, Thompson LH. The human XRCC9 gene corrects chromosomal instability and mutagen sensitivities in CHO UV40 cells. Proc Natl Acad Sci USA 1997;94:9232-7.
92. Demuth I, Wlodarski M, Tipping AJ, Morgan NV, de Winter JP, Thiel M, Grasl S, Schindler D, D'Andrea AD, Altay C, Kayserili H, Zatterale A, Kunze J, Ebell W, Mathew CG, Joenje H, Sperling K, Digweed M. Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9. Eur J Hum Genet 2000;8:861-8.
93. Faivre L, Guardiola P, Lewis C, Dokal I, Ebell W, Zatterale A, Altay C, Poole J, Stones D, Kwee ML, van Weel-Sipman M, Havenga C, Morgan N, de Winter J, Digweed M, Savoia A, Pronk J, de Ravel T, Jansen S, Joenie H, Gluckman E, Mathew CG. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Blood 2000;96:4064-70.
94. Garcia-Higuera I, Kuang Y, Näf D, Wasik J, D'Andrea AD. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol Cell Biol 1999;19:4866-73.
95. de Winter JP, van Der Weel L, de Groot J, Stone S, Waisfisz Q, Arwert F, Scheper RJ, Kruyt FA, Hoatlin ME, Joenje H. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet 2000;9:2665-74.
96. Medhurst AL, Huber PA, Waisfisz Q, de Winter JP, Mathew CG. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum Mol Genet 2001;10:423-9.
97. Waisfisz Q, de Winter JP, Kruyt FA, de Groot J, van der Weel L, Dijkmans LM, Zhi Y, Arwert F, Scheper RJ, Youssoufian H, Hoatlin ME, Joenje H. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc Natl Acad Sci USA 1999;96:10320-5.
98. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fancani anaemia. Nat Rev Genet 2001;2:446-57.
99. Moses RE. DNA damage processing defects and disease. Annu Rev Genomics Hum Genet 2001;2:41-68.
100. Futaki M, Liu JM. Chromosomal breakage syndromes and the BRCA1 genome surveillance complex. Trends Mol Med 2001;7:560-5.
101. Grompe M, D'Andrea A. Fanconi anemia and DNA repair. Hum Mol Genet 2001;10:2253-9.
102. Escarceller M, Buchwald M, Singleton BK, Jeggo PA, Jackson SP, Moustacchi E, Papadopoulo D. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining. J Mol Biol 1998;279:375-85.
103. Escarceller M, Rousset S, Moustacchi E, Papadopoulo D. The fidelity of double strand breaks processing is impaired in complementation groups B and D of Fanconi anemia, a genetic instability syndrome. Somat Cell Mol Genet 1997;23:401-11.
104. Runger TM, Sobotta P, Dekant B, Moller K, Bauer C, Kraemer KH. In-vivo assessment of DNA ligation efficiency and fidelity in cells from patients with Fanconi's anemia and other cancer-prone hereditary disorders. Toxicol Lett 1993;67:309-24.
105. Smith J, Andrau JC, Kallenbach S, Laquerbe A, Doyen N. Papadopoulo D. Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia. J Mol Biol 1998;281:815-25.
106. Novotna B, Goetz P, Surkova NI. Effects of alkylating agents on lymphocytes from controls and from patients with Fanconi's anemia. Studies of sister chromatid exchanges, chromosome aberrations, and kinetics of cell division. Hum Genet 1979;49:41-50.
107. Sala-Trepat M, Rouillard D, Escarceller M, Laquerbe A, Moustacchi E, Papadopoulo D. Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp Cell Res 2000;260:208-15.
108. Centurion SA, Kuo HR, Lambert WC. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Exp Cell Res 2000;260:216-21.
109. Hoehn H, Kubbies M, Schindler D, Poot M, Rabinovitch PS. BrdU-Hoechst flow cytometry links the cell kinetic defect of Fanconi anaemia to oxygen hypersensitivity. In: Schroeder-Kurth TM, Auerbach AD, Obe G, eds. Fanconi anaemia: clinical, cytogenetic and experimental aspects. Berlin: Springer-Verlag, 1989:162-73.
110. Joenje H, Arwert F, Eriksson AW, de Koning H, Oostra AB. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature 1981;290:142-3.
111. Joenje H, Gille JJP. Oxygen metabolism and chromosomal breakage in Fanconi anaemia. In: Schroeder-Kurth TM, Auerbach AD, Obe G, eds. Fanconi anaemia: clinical, cytogenetic and experimental aspects of Fanconi anaemia. Berlin: Springer-Verlag, 1989:174-82.
112. Clarke AA, Philpott NJ, Gordon-Smith EC, Rutherford TR. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. Br J Haematol 1997;96:240-7.
113. Kruyt FAE, Hoshino T, Liu JM, Joseph P, Jaiswal AK, Youssoufian H. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood 1998;92:3050-6.
114. Futaki M, Igarashi T, Watanabe S, Kajigaya S, Tatsuguchi A, Wang J, Liu JM. The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis 2002;23:67-72.
115. Rosselli F. Fanconi anaemia syndrome and apoptosis: state of the art. Apoptosis 1998;3:229-36.
116. Kruyt FA, Dijkmans LM, Van DBTK, Joenje H. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood 1996;87:938-48.
117. Rosselli F, Ridet A, Soussi T, Duchaud E, Alapetite C, Moustacchi E. p53-dependent pathway of radio-induced apoptosis is altered in Fanconi onemia. Oncogene 1995;10:9-17.
118. Ridet A, Guillouf C, Duchaud E, Cundari E, Fiore M. Moustacchi E, Rosselli F. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res 1997;57:1722-30.
119. Rey JP, Scott R, Muller H. Apoptosis is not involved in the hypersensitivity of Fanconi anemia cells to mitomycin C. Cancer Genet Cytogenet 1994;75:67-71.
120. Pang Q, Keeble W, Christianson TA, Faulkner GR, Bagby GC. FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity. EMBO J 2001;20:4478-89.
121. Cumming RC, Lightfoot J, Beard K, Youssoufian H, O'Brien PJ, Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med 2001;7:814-20.
122. Leteurtre F, Li X, Guardiola P, Le Roux G, Sergere JC, Richard P, Carosella ED, Gluckman E. Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br J Haematol 1999;105:883-93.
123. Hanson H, Mathew CG, Docherty Z, Mackie Ogilvie C. Telomere shortening in Fanconi anaemia demonstrated by a direct FISH approach. Cytogenet Cell Genet 2001;93:203-6.
124. Ball SE, Gibson FM, Rizzo S, Tooze JA, Marsh JC, Gordon-Smith EC. Progressive telomere shortening in aplastic anemia. Blood 1998;91:3582-92.
125. Boultwood J, Fidler C, Kusec R, Rack K, Elliott PJ, Atoyebi O, Chapman R, Oscier DG, Wainscoat JS. Telomere length in myelodysplastic syndromes. Am J Hematol 1997;56:266-71.
126. Callen E, Samper E, Ramirez MJ, Creus A, Marcos R, Ortega JJ, Olive T, Badell I, Blasco MA, Surralles J. Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia. Hum Mol Genet 2002;11:439-44.
127. Stark R, Thierry D, Richard P, Gluckman E. Long-term bone marrow culture in Fanconi's anaemia. Br J Haematol 1993;83:554-9.
128. Rosselli F, Sanceau J, Wietzerbin J, Moustacchi E. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6. Hum Genet 1992;89:42-8.
129. Stark R, Andre C, Thierry D, Cherel M, Galibert F, Gluckman E. The expression of cytokine and cytokine receptor genes in long-term bone marrow culture in congenital and acquired bone marrow hypoplasias. Br J Haematol 1993;83:560.
130. de Cremoux P, Gluckman E, Podgorniak MP, Menier C, Thierry D, Calvo F, Socie G. Decreased IL-1 beta and TNF alpha secretion in long-term bone marrow culture supernatant from Fanconi's anaemia patients. Eur J Haematol 1996;57:202-7.
131. Schultz JC, Shahidi NT. Tumor necrosis factor-alpha overproduction in Fanconi's anemia. Am J Hematol 1993;42:196-201.
132. Rosselli F, Sanceau J, Gluckman E, Wietzerbin J, Moustacchi E. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood 1994;83:1216-25.
133. Lensch MW, Rathbun RK, Olson SB, Jones GR, Bagby GC Jr. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia. Leukemia 1999;13:1784-9.
134. Dokal I. The genetics of Fanconi's anaemia. Baillieres Best Pract Res Clin Haematol 2000;13:407-25.
135. McMahon LW, Walsh CE, Lambert MW. Human alpha spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex. J Biol Chem 1999;274:32904-8.
136. McMahon LW, Sangerman J, Goodman SR, Kumaresan K, Lambert MW. Human alpha spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links. Biochemistry 2001;40:7025-34.
137. Kumaresan KR, Lambert MW. Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links. Carcinogenesis 2000;21:741-51.
138. Otsuki T, Kajigaya S, Ozawa K, Liu JM. SNX5, o new member of the sorting nexin family, binds to the Fanconi anemia complementation group A protein. Biochem Biophys Res Commun 1999;265:630-5.
139. Hoshino T, Wang JX, Devetten MP, Iwata N, Kajigaya S, Wise RJ, Liu JM, Youssoufian H. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression. Blood 1998;91:4379-86.
140. Kruyt FA, Dijkmans LM, Arwert F, Joenje H. Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase. Cancer Res 1997;57:2244-51.
141. Kupfer GM, Yamashita T, Näf D, Suliman A, Asano S, D'Andrea AD. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Blood 1997;90:1047-54.
142. Hoatlin ME, Zhi Y, Ball H, Silvey K, Melnick A, Stone S, Arai S, Hawe N, Owen G, Zelent A, Licht JD. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood 1999;94:3737-47.
143. Pang Q, Fagerlie S, Christianson TA, Keeble W, Faulkner G, Diaz J, Rathbun RK, Bagby GC. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors. Mol Cell Biol 2000;20:4724-35.